|
SNTI
|
Senti Biosciences, Inc.
|
US
|
NASDAQ
|
|
SURF
|
Surface Oncology, Inc.
|
US
|
NASDAQ
|
|
TCBP
|
TC BioPharm (Holdings) plc
|
US
|
NASDAQ
|
|
TCRR
|
TCR2 Therapeutics Inc.
|
US
|
NASDAQ
|
|
TIL
|
Instil Bio, Inc.
|
US
|
NASDAQ
|
|
XLO
|
Xilio Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ZYME
|
Zymeworks Inc.
|
US
|
NASDAQ
|
|
CHM
|
Chimeric Therapeutics Limited NL
|
AU
|
ASX
|
|
IMM
|
Immutep Limited
|
AU
|
ASX
|
|
IMU
|
Imugene Limited
|
AU
|
ASX
|
|
ARGNF
|
Argen X Nv
|
US
|
OTC
|
|
CLCS
|
Cell Source, Inc
|
US
|
OTC
|
|
CMVLF
|
Cellectis Romainvil
|
US
|
OTC
|
|
HNSBF
|
Hansa Medical Ab Malmo
|
US
|
OTC
|
|
IDRSF
|
Idorsia Ag
|
US
|
OTC
|
|
IMUC
|
Immunocellular Thera
|
US
|
OTC
|
|
IPHYF
|
Innate Pharma
|
US
|
OTC
|
|
IUGNF
|
IMUGENE LTD
|
US
|
OTC
|
|
JWCTF
|
Jw Cayman Therapeutics CO Ltd
|
US
|
OTC
|
|
MLLCF
|
Molecular Partners Ag
|
US
|
OTC
|